|1.||Pasini, Diego: 4 articles (05/2015 - 04/2004)|
|2.||Gil, Jesús: 3 articles (11/2014 - 02/2005)|
|3.||Helin, Kristian: 3 articles (11/2009 - 04/2004)|
|4.||Huang, Jennifer M: 2 articles (07/2015 - 05/2015)|
|5.||Piunti, Andrea: 2 articles (05/2015 - 01/2011)|
|6.||Sneige, Nour: 2 articles (01/2014 - 12/2011)|
|7.||Ueno, Naoto T: 2 articles (01/2014 - 12/2011)|
|8.||Valero, Vicente: 2 articles (01/2014 - 12/2011)|
|9.||Huo, Lei: 2 articles (01/2014 - 12/2011)|
|10.||Gong, Yun: 2 articles (01/2014 - 12/2011)|
|1.||Spinal Dysraphism (Spina Bifida)
|2.||Stomach Neoplasms (Stomach Cancer)
10/01/2012 - "enhancer of zeste homologue 2 (EZH2) and B lymphoma Mo-MLV insertion region 1 homolog (BMI-1) are the best-characterized polycomb group proteins; their deregulation contributes to the development of many malignancies including gastric cancers. "
10/01/2012 - "In the present study, we investigated the expression of the polycomb group proteins EZH2 and BMI-1 and the associated proteins H3 trimethylation at lysine 27 and DNA methyltransferase 3B in advanced gastric cancers. "
11/01/2014 - "Polycomb group proteins (PcGs) are essential epigenetic regulators that play key roles in development, pluripotency, senescence, and cancer. "
01/01/2014 - "Polycomb group proteins and MYC: the cancer connection."
06/01/2013 - "Trithorax and polycomb group proteins antagonistically regulate the transcription of many genes, and cancer can result from the disruption of this regulation. "
10/01/2012 - "Overexpression of polycomb group proteins is associated with poor prognoses in some types of cancers but with favorable prognoses in others. "
10/01/2012 - "The polycomb group proteins have recently captured the attention of cancer biologists. "
03/31/2011 - "Furthermore, we found that Evi1 binds to several polycomb group proteins and recruits polycomb repressive complexes for PTEN down-regulation, which shows a novel epigenetic mechanism of AKT/mTOR activation in leukemia. "
02/14/2013 - "In addition to implicating a role for PRC2 in the pathogenesis of MLL-fusion leukemia, our results suggest, more generally, that Trithorax and Polycomb group proteins can cooperate with one another to maintain aberrant lineage programs in cancer."
06/01/2007 - "Here, we have investigated the role of Polycomb group proteins in the establishment and maintenance of the aberrant silencing of tumor suppressor genes during transformation induced by the leukemia-associated PML-RARalpha fusion protein. "
12/01/2006 - "Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells."
|5.||Hepatocellular Carcinoma (Hepatoma)
01/01/2014 - "In ES cells, interactions between OCT3/4, NANOG, SOX2 and Polycomb Group proteins at the Ahr promoter repress AHR expression, which can also be repressed by ectopic expression of reprogramming factors in hepatoma cells. "
06/01/2013 - "Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins."
09/01/2009 - "Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma."
08/01/2008 - "The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma."
|1.||Proteins (Proteins, Gene)
|3.||Tretinoin (Retinoic Acid)
|4.||DNA methyltransferase 3B
|6.||Histone Deacetylase Inhibitors
|7.||AMP-Activated Protein Kinases
|9.||DNA (Deoxyribonucleic Acid)